Sildenafil, a specific phosphodiesterase type 5 (PDE5) inhibitor, selectively relaxes pulmonary vessels, reduces pulmonary vascular resistance, improves vascular remodeling, and inhibits pulmonary hypertension. The gene discussed is PDE5A; the disease is pulmonary hypertension.